Plenary Presentation to be Followed by Poster Presentation Highlighting HLD-0915 Clinical DataBOSTON, Oct. 14, 2025 (GLOBE ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer cell survival pathways.

Swedish company, which speeds up prostate cancer diagnosis, chooses Milton Park for its first UK laboratory Milton Park has ...

The prostate is a gland that is about the size of a walnut which sits just below the bladder within the pelvis. It surrounds ...

“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...

A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.